keyword
MENU ▼
Read by QxMD icon Read
search

IUD levonorgestrel

keyword
https://www.readbyqxmd.com/read/27861709/contraceptive-use-in-the-nordic-countries
#1
Ingela Lindh, Finn Egil Skjeldestad, Kristina Gemzell-Danielsson, Oskari Heikinheimo, Helena Hognert, Ian Milsom, Øjvind Lidegaard
The aim was to compare contraceptive use in the Nordic countries and to assess compliance with recommendations from the European Medicines Agency regarding the use of combined oral contraceptives (COC) containing low dose estrogen and levonorgestrel, norethisterone or norgestimate MATERIAL AND METHODS: Data on hormonal contraceptive prescriptions and sales figures for copper intrauterine devices (Cu-IUD) were obtained from national databases and manufacturers in Denmark, Finland, Iceland, Norway and Sweden 2010-2013 RESULTS: Contraceptive use was highest in Denmark (42%) and Sweden (41%), followed by Finland (40%)...
November 12, 2016: Acta Obstetricia et Gynecologica Scandinavica
https://www.readbyqxmd.com/read/27836586/intrauterine-contraception-after-medical-abortion-factors-affecting-success-of-early-insertion
#2
Elina Pohjoranta, Satu Suhonen, Maarit Mentula, Oskari Heikinheimo
OBJECTIVE: To assess the success and factors affecting early intrauterine device (IUD) provision after first trimester medical termination of pregnancy (MTOP). STUDY DESIGN: Subgroup analysis of a randomized contraceptive trial assessing the long-term effects of early provision of intrauterine contraception following abortion. Altogether, 606 women undergoing MTOP were included and followed for 3 months. The intervention group (n=307) was offered an IUD (either the levonorgestrel-releasing intrauterine system or copper-IUD) at a follow-up visit 1-4 weeks after MTOP...
November 9, 2016: Contraception
https://www.readbyqxmd.com/read/27818117/-induced-abortion-guidelines-for-clinical-practice%C3%A2-%C3%A2-text-of-the-guidelines-short-text
#3
C Vayssière, A Gaudineau, L Attali, K Bettahar, S Eyraud, P Faucher, P Fournet, D Hassoun, M Hatchuel, C Jamin, B Letombe, T Linet, M Msika Razon, A Ohanessian, H Segain, S Vigoureux, N Winer, S Wylomanski, A Agostini
OBJECTIVE: Develop recommendations for the practice of induced abortion. MATERIALS AND METHODS: The Pubmed database, the Cochrane Library and the recommendations from the French and foreign Gyn-Obs societies or colleges have been consulted. RESULTS: The number of induced abortions (IA) has been stable for several decades. There are a lot of factors explaining the choice of abortion when there is an unplanned pregnancy (UPP). Early initiation and choice of contraception in connection to the woman's life are associated with lower NSP...
November 3, 2016: Journal de Gynécologie, Obstétrique et Biologie de la Reproduction
https://www.readbyqxmd.com/read/27677612/women-with-epilepsy-initiating-a-progestin-iud-a-prospective-pilot-study-of-safety-and-acceptability
#4
Anne R Davis, Heva J Saadatmand, Alison Pack
OBJECTIVE: Effective contraception enables women with epilepsy (WWE) to plan their pregnancies and improve outcomes for themselves and their children. Although popular among all women, complex drug interactions limit the efficacy and safety of oral contraceptives (OCs) for WWE. We sought to explore the safety, acceptability, and pharmacokinetic impact of a progestin-containing intrauterine device (IUD) in WWE. METHODS: We enrolled 20 women with well-controlled epilepsy and a stable antiepileptic drug (AED) regimen and who were initiating a progestin-containing IUD (levonorgestrel 52 mg) in a prospective, observational study...
November 2016: Epilepsia
https://www.readbyqxmd.com/read/27676405/update-on-emergency-contraception
#5
Wing Kay Fok, Paul D Blumenthal
PURPOSE OF REVIEW: Emergency contraception provides a critical and time-sensitive opportunity for women to prevent undesired pregnancy after intercourse. Both access and available options for emergency contraception have changed over the last several years. RECENT FINDINGS: Emergency contraceptive pills can be less effective in obese women. The maximum achieved serum concentration of levonorgestrel (LNG) is lower in obese women than women of normal BMI, and doubling the dose of LNG (3 mg) increases its concentration maximum, approximating the level in normal BMI women receiving one dose of LNG...
December 2016: Current Opinion in Obstetrics & Gynecology
https://www.readbyqxmd.com/read/27671673/extended-use-up-to-5-years-of-the-etonogestrel-releasing-subdermal-contraceptive-implant-comparison-to-levonorgestrel-releasing-subdermal-implant
#6
Moazzam Ali, Ayse Akin, Luis Bahamondes, Vivian Brache, Ndema Habib, Sihem Landoulsi, David Hubacher
STUDY QUESTION: Is it possible to extend the use of the 3-year one-rod etonogestrel (ENG)-releasing subdermal contraceptive implant to 5 years? SUMMARY ANSWER: The extended use of the one-rod ENG-releasing subdermal contraceptive implant showed 100% efficacy in years 4 and 5. WHAT IS KNOWN ALREADY: The initial regulated trials on the ENG-releasing subdermal contraceptive implant conducted in the 1990 s were designed to measure cumulative 3-year efficacy...
November 2016: Human Reproduction
https://www.readbyqxmd.com/read/27607867/levonorgestrel-intrauterine-device-as-an-endometrial-cancer-prevention-strategy-in-obese-women-a-cost-effectiveness-analysis
#7
Joseph A Dottino, Vic Hasselblad, Angeles Alvarez Secord, Evan R Myers, Junzo Chino, Laura J Havrilesky
OBJECTIVE: To estimate the cost-effectiveness of the levonorgestrel intrauterine device (IUD) as an endometrial cancer prevention strategy in obese women. METHODS: A modified Markov model was used to compare IUD placement at age 50 with usual care among women with a body mass index (BMI, kg/m) 40 or greater or BMI 30 or greater. The effects of obesity on incidence and survival were incorporated. The IUD was assumed to confer a 50% reduction in cancer incidence over 5 years...
October 2016: Obstetrics and Gynecology
https://www.readbyqxmd.com/read/27591814/temporary-removal-use-of-intrauterine-devices-in-nulliparous-women
#8
Patricia A Lohr, Richard Lyus, Sarah Prager
No abstract text is available yet for this article.
August 31, 2016: Contraception
https://www.readbyqxmd.com/read/27540128/expanding-access-to-a-new-more-affordable-levonorgestrel-intrauterine-system-in-kenya-service-delivery-costs-compared-with-other-contraceptive-methods-and-perspectives-of-key-opinion-leaders
#9
Kate H Rademacher, Marsden Solomon, Tracey Brett, John H Bratt, Claire Pascual, Jesse Njunguru, Markus J Steiner
BACKGROUND: The levonorgestrel intrauterine system (LNG IUS) is one of the most effective forms of contraception and offers important non-contraceptive health benefits. However, it is not widely available in developing countries, largely due to the high price of existing products. Medicines360 plans to introduce its new, more affordable LNG IUS in Kenya. The public-sector transfer price will vary by volume between US$12 to US$16 per unit; for an order of 100,000 units, the public-sector transfer price will be approximately US$15 per unit...
August 11, 2016: Global Health, Science and Practice
https://www.readbyqxmd.com/read/27437931/the-effects-of-hormones-and-vaginal-microflora-on-the-glycome-of-the-female-genital-tract-cervical-vaginal-fluid
#10
Bernard J Moncla, Catherine A Chappell, Brian M Debo, Leslie A Meyn
In this study, we characterized the glycome of cervical-vaginal fluid, collected with a Catamenial cup. We quantified: glycosidase levels; sialic acid and high mannose specific lectin binding; mucins, MUC1, MUC4, MUC5AC, MUC7; and albumin in the samples collected. These data were analyzed in the context of hormonal status (day of menstrual cycle, hormonal contraception use) and role, if any, of the type of the vaginal microflora present. When the Nugent score was used to stratify the subjects by microflora as normal, intermediate, or bacterial vaginosis, several important differences were observed...
2016: PloS One
https://www.readbyqxmd.com/read/27421765/the-safety-of-intrauterine-devices-in-breastfeeding-women-a-systematic-review
#11
REVIEW
Erin N Berry-Bibee, Naomi K Tepper, Tara C Jatlaoui, Maura K Whiteman, Denise J Jamieson, Kathryn M Curtis
OBJECTIVES: To investigate levonorgestrel (LNG)-releasing and copper-bearing (Cu) intrauterine device (IUD) safety among breastfeeding women and, for Cu-IUD use, breastfeeding performance and infant health. STUDY DESIGN: Systematic review. METHODS: We searched PubMed, Embase, Cochrane Library and clinicaltrials.gov for articles through January 2016. We included studies of Cu-IUD or LNG-IUD users comparing IUD-specific (perforation, expulsion) and other contraceptive-related (infection, removal/cessation due to bleeding/pain and other adverse events) outcomes for breastfeeding vs...
December 2016: Contraception
https://www.readbyqxmd.com/read/27374735/immunologic-evaluation-of-the-endometrium-with-a-levonorgestrel-intrauterine-device-in-solid-organ-transplant-women-and-healthy-controls
#12
Caron R Kim, Otoniel Martinez-Maza, Larry Magpantay, Clara Magyar, Jeffrey Gornbein, Radhika Rible, Peggy Sullivan
OBJECTIVES: To describe the endometrial milieu of stable transplant patients and healthy women before and after levonorgestrel intrauterine system (LNG-IUS) insertion. STUDY DESIGN: Women between 18-45 years of age desiring LNG-IUS insertion were enrolled with a 2:1 ratio of healthy to stable solid organ transplant patients. The first visit entailed a blood draw, uterine lavage and endometrial biopsy followed by LNG-IUS insertion. Follow-up visit involved a repeat serum draw, uterine lavage and endometrial biopsy...
June 30, 2016: Contraception
https://www.readbyqxmd.com/read/27373540/medications-to-ease-intrauterine-device-insertion-a-systematic-review
#13
Lauren B Zapata, Tara C Jatlaoui, Polly A Marchbanks, Kathryn M Curtis
BACKGROUND: Potential barriers to intrauterine device (IUD) use include provider concern about difficult insertion, particularly for nulliparous women. OBJECTIVE: This study aims to evaluate the evidence on the effectiveness of medications to ease IUD insertion on provider outcomes (i.e., ease of insertion, need for adjunctive insertion measures, insertion success). SEARCH STRATEGY: We searched the PubMed database for peer-reviewed articles published in any language from database inception through February 2016...
June 29, 2016: Contraception
https://www.readbyqxmd.com/read/27364100/safety-of-hormonal-contraception-and-intrauterine-devices-among-women-with-depressive-and-bipolar-disorders-a-systematic-review
#14
H Pamela Pagano, Lauren B Zapata, Erin N Berry-Bibee, Kavita Nanda, Kathryn M Curtis
BACKGROUND: Women with depressive or bipolar disorders are at an increased risk for unintended pregnancy. OBJECTIVE: To examine the safety of hormonal contraception among women with depressive and bipolar disorders. METHODS: We searched for articles published through January 2016 on the safety of using any hormonal contraceptive method among women with depressive or bipolar disorders, including those who had been diagnosed clinically or scored above threshold levels on a validated screening instrument...
June 27, 2016: Contraception
https://www.readbyqxmd.com/read/27349294/unprotected-intercourse-in-the-2-weeks-prior-to-requesting%C3%A2-emergency-intrauterine-contraception
#15
Jessica N Sanders, Laura Howell, Hanna M Saltzman, E Bimla Schwarz, Ivana S Thompson, David K Turok
BACKGROUND: Previous emergency contraception studies have excluded women who report >1 episode of unprotected or underprotected intercourse. Thus, clinical recommendations are based on exposure to a single episode of underprotected intercourse. OBJECTIVE: We sought to assess the prevalence and timing of underprotected intercourse episodes among women requesting emergency contraception and to examine the probability of pregnancy following an emergency contraception regimen including placement of either a copper intrauterine device or a levonorgestrel intrauterine device with simultaneous administration of an oral levonorgestrel pill in women reporting multiple underprotected intercourse episodes, including episodes beyond the Food and Drug Administration-approved emergency contraception time frame (6-14 days)...
June 24, 2016: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/27343306/clinicopathologic-characteristics-and-treatment-features-of-women-with-the-incidental-diagnosis-of-endometrial-adenocarcinoma-during-infertility-follow-up-in-ankara-turkey
#16
Tayfun Gungor, Nilufer Cetinkaya, Hakan Yalcin, Sema Zergeroglu, Salim Erkaya
OBJECTIVE: The aim of this study was to investigate the clinical and laboratory features of patients with the incidental diagnosis of endometrial adenocarcinoma (EC) during infertility work-up, with special attention given to treatment approaches, recurrence rate, and fertility outcome. MATERIAL AND METHODS: The medical records of 577 patients who were diagnosed with EC and treated between 2007 and 2013 were included in the study. Out of 577 EC patients, 5.1% (n = 30) were ≤ 40 years of age...
June 2016: Taiwanese Journal of Obstetrics & Gynecology
https://www.readbyqxmd.com/read/27312266/corrigendum-to-rowe-p-et-al-safety-and-efficacy-in-parous-women-of-a-52-mg-levonorgestrel-medicated-intrauterine-device-a-7-year-randomized-comparative-study-with-the-tcu380a-contraception-2016-93-498-506
#17
Patrick Rowe, Tim Farley, Alexandre Peregoudov, Gilda Piaggio, Simone Boccard, Sihem Landoulsi, Olav Meirik
No abstract text is available yet for this article.
September 2016: Contraception
https://www.readbyqxmd.com/read/27263041/the-safety-of-intrauterine-contraception-initiation-among-women-with-current-asymptomatic-cervical-infections-or-at-increased-risk-of-sexually-transmitted-infections
#18
Tara C Jatlaoui, Katharine B Simmons, Kathryn M Curtis
OBJECTIVE: The objective was to assess risk of pelvic inflammatory disease (PID) among women with current asymptomatic undiagnosed cervical infection or who are at high risk of sexually transmitted infections (STIs), comparing those who have a copper-bearing (Cu-) or levonorgestrel (LNG-) intrauterine device (IUD) placed with women who do not. STUDY DESIGN: We searched PubMed and Cochrane Library for articles from January 1984 through January 2016 addressing our objective...
June 1, 2016: Contraception
https://www.readbyqxmd.com/read/27234874/safety-and-effectiveness-data-for-emergency-contraceptive-pills-among-women-with-obesity-a-systematic-review
#19
Tara C Jatlaoui, Kathryn M Curtis
OBJECTIVE: This study aims to determine whether emergency contraceptive pills (ECPs) are less safe and effective for women with obesity compared with those without obesity. STUDY DESIGN: We searched PubMed for articles through November 2015 regarding the safety and effectiveness of ECPs [ulipristal acetate (UPA), levonorgestrel (LNG) and combined estrogen and progestin] among obese users. We assessed study quality using the United States Preventive Services Task Force evidence grading system...
May 24, 2016: Contraception
https://www.readbyqxmd.com/read/27187927/the-use-of-long-acting-reversible-contraceptives-and-the-relationship-between-discontinuation-rates-due-to-menopause-and-to-female-and-male-sterilizations
#20
Jessica Mayra Ferreira, Ilza Monteiro, Sara Castro, Marina Villarroel, Carolina Silveira, Luis Bahamondes
Introduction Women require effective contraception until they reach menopause. The long acting reversible contraceptives (LARC) and the depot-medroxyprogesterone acetate (DMPA, Depo-Provera®, Pfizer, Puurs, Belgium) are great options and can replace possible sterilizations. Purpose To assess the relationship between the use of LARCs and DMPA and terminations ascribed to menopause and sterilizations in a Brazilian clinic. Methods We reviewed the records of women between 12 and 50 years of age attending the clinic that chose to use a LARC method or DMPA...
May 2016: Revista Brasileira de Ginecologia e Obstetrícia
keyword
keyword
73058
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"